Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.42, read 2026-10-28
Ethical does not pass the values gate
Price23.69 USD
Fair value43.98
Ethical score30.0/100
Our investment reviews on this name
2026-10-02Read Markdown27.18-12.8% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-08-28Read Distribution27.77-14.7% to today ✓Markup gives way to Distribution after a 28% slide in 8 weeks
2026-07-02Read Markup38.52-38.5% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
eToro Group Ltd. holds its Markdown at $23.69. The statistical read favours the sellers, held for 50 days.
As held on the ledger · 2026-10-27
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 50 days
Price at the screen
$23.69
Valuation
8.74 trailing · 7.90 forward price to earnings
Values screen
FAIL· score 30.0
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: financial services
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
eToro does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ETOR's ethical verdict changes
Today ETOR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · Ethical Consumer Boycotts List
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on Ethical Consumer Boycotts List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 85.6% margin of safety to the base estimate.
Third-party analyst targets: 15 covering, consensus Buy. The average target sits +82% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Trading Apps Hit Our Ethical Red Line
Picture a young investor in Tel Aviv tapping into crypto and stocks through one slick app. That ease comes from a financial services business we screen out on principle, regardless of any apparent value on offer.
We pass for one straightforward reason. The ethical filter blocks anything in this sector outright, and no margin of safety calculation or analyst target changes that stance.
Revenue has already dropped 36 percent, margins sit at just 2 percent, and the model carries the usual market swings that can erase apparent cheapness fast. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Israel and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ETOR trades on Nasdaq (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markdown$23.69-4.7%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-10-21Markdown$24.86+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-10-14Markdown$24.86-8.5%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-10-02Markdown · changed$27.18-2.1%Entry 6
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 22.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-07-28Markup$35.98-6.6%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-07-18Markup$38.52+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (15 analysts) rates it buy, with a mean price target of $56.
2026-07-03Markup$38.52+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$38.52Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.